306 related articles for article (PubMed ID: 20435730)
21. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli.
Ma C; Sim S; Shi W; Du L; Xing D; Zhang Y
FEMS Microbiol Lett; 2010 Feb; 303(1):33-40. PubMed ID: 20041955
[TBL] [Abstract][Full Text] [Related]
22. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
Xu Y; Cui P; Zhang Y; Zhang W
Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
[TBL] [Abstract][Full Text] [Related]
23. High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli.
Mohiuddin SG; Massahi A; Orman MA
Microbiol Spectr; 2022 Feb; 10(1):e0225321. PubMed ID: 35196813
[TBL] [Abstract][Full Text] [Related]
24. Bactericidal activity of alpha-bromocinnamaldehyde against persisters in Escherichia coli.
Shen Q; Zhou W; Hu L; Qi Y; Ning H; Chen J; Mo H
PLoS One; 2017; 12(7):e0182122. PubMed ID: 28750057
[TBL] [Abstract][Full Text] [Related]
25. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.
Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929
[TBL] [Abstract][Full Text] [Related]
26. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
[TBL] [Abstract][Full Text] [Related]
27. Composition of the outgrowth medium modulates wake-up kinetics and ampicillin sensitivity of stringent and relaxed Escherichia coli.
Varik V; Oliveira SR; Hauryliuk V; Tenson T
Sci Rep; 2016 Feb; 6():22308. PubMed ID: 26923949
[TBL] [Abstract][Full Text] [Related]
28. Single Cell Killing Kinetics Differentiate Phenotypic Bacterial Responses to Different Antibacterial Classes.
Zhang Y; Kepiro I; Ryadnov MG; Pagliara S
Microbiol Spectr; 2023 Feb; 11(1):e0366722. PubMed ID: 36651776
[TBL] [Abstract][Full Text] [Related]
29. Putrescine controls the formation of Escherichia coli persister cells tolerant to aminoglycoside netilmicin.
Tkachenko AG; Kashevarova NM; Karavaeva EA; Shumkov MS
FEMS Microbiol Lett; 2014 Dec; 361(1):25-33. PubMed ID: 25283595
[TBL] [Abstract][Full Text] [Related]
30. Persister cells mediate tolerance to metal oxyanions in Escherichia coli.
Harrison JJ; Ceri H; Roper NJ; Badry EA; Sproule KM; Turner RJ
Microbiology (Reading); 2005 Oct; 151(Pt 10):3181-3195. PubMed ID: 16207903
[TBL] [Abstract][Full Text] [Related]
31.
Kim H; Oh S; Song S
J Microbiol Biotechnol; 2024 Apr; 34(4):854-862. PubMed ID: 38326923
[No Abstract] [Full Text] [Related]
32. Multidrug tolerance of biofilms and persister cells.
Lewis K
Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.
Wiuff C; Zappala RM; Regoes RR; Garner KN; Baquero F; Levin BR
Antimicrob Agents Chemother; 2005 Apr; 49(4):1483-94. PubMed ID: 15793130
[TBL] [Abstract][Full Text] [Related]
34. Persister control by leveraging dormancy associated reduction of antibiotic efflux.
Roy S; Bahar AA; Gu H; Nangia S; Sauer K; Ren D
PLoS Pathog; 2021 Dec; 17(12):e1010144. PubMed ID: 34890435
[TBL] [Abstract][Full Text] [Related]
35. Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
Karki P; Mohiuddin SG; Kavousi P; Orman MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094133
[TBL] [Abstract][Full Text] [Related]
36. MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth.
Cho J; Carr AN; Whitworth L; Johnson B; Wilson KS
Microbiology (Reading); 2017 Mar; 163(3):308-321. PubMed ID: 28113053
[TBL] [Abstract][Full Text] [Related]
37. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
VandenBerg KE; Ahn S; Visick JE
Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
[TBL] [Abstract][Full Text] [Related]
38. The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation.
Dewachter L; Bollen C; Wilmaerts D; Louwagie E; Herpels P; Matthay P; Khodaparast L; Khodaparast L; Rousseau F; Schymkowitz J; Michiels J
mBio; 2021 Aug; 12(4):e0070321. PubMed ID: 34340538
[TBL] [Abstract][Full Text] [Related]
39. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
Völzing KG; Brynildsen MP
mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
[TBL] [Abstract][Full Text] [Related]
40. Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides.
Chen X; Zhang M; Zhou C; Kallenbach NR; Ren D
Appl Environ Microbiol; 2011 Jul; 77(14):4878-85. PubMed ID: 21622798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
